Morgan Stanley
NYSE:MSFinancial - Capital Markets
+$0.33 today
- Market cap
- $285.76B
- Beta
- 1.22
- P/E (TTM)
- 19.5
- EPS (TTM)
- $11.57
- Dividend yield
- 1.78%
Volume 5.15M
Average 6.07M
MS Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Morgan StanleyNYSE: MS
Research & Development · Q3 FY2026 · quarter ended Sep 2026
Research & development remains negative
Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How MS compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for MS, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
| LTM Sep 2026 | £0 GBP | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | — | — | 0.0% | |
| LTM Jun 2026 | ¥0 JPY | — | — | 0.0% | |
| Peer median (excluding MS) | — | — | — | 0.0% | |
Competitors are the stored peer set for MS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 57.78B | 62.48B | 88.29B | 103.15B | 114.98B |
| Cost of Revenue | 1.37B | 12.55B | 38.15B | 45.79B | 49.37B |
| Gross Profit | 56.41B | 49.93B | 50.14B | 57.36B | 65.62B |
| Gross Margin | 97.6% | 79.9% | 56.8% | 55.6% | 57.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 25.27B | 23.96B | 25.1B | 27.14B | 30.25B |
| Operating Expenses | 36.74B | 35.84B | 38.32B | 39.76B | 43.66B |
| Depreciation & Amortization | 4.22B | 4B | 4.26B | 5.16B | 4.66B |
| EBITDA | 23.88B | 18.09B | 16.07B | 22.76B | 26.61B |
| EBITDA Margin | 41.3% | 28.9% | 18.2% | 22.1% | 23.1% |
| Operating Income | 19.67B | 14.09B | 11.81B | 17.6B | 21.95B |
| Operating Margin | 34.0% | 22.6% | 13.4% | 17.1% | 19.1% |
| Interest Income | 9.41B | 21.6B | 45.85B | 54.14B | 59.06B |
| Interest Expense | 1.37B | 12.27B | 37.62B | 45.52B | 49.02B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 19.67B | 14.09B | 11.81B | 17.6B | 21.95B |
| Pre-Tax Margin | 34.0% | 22.6% | 13.4% | 17.1% | 19.1% |
| Income Tax Expense | 4.55B | 2.91B | 2.58B | 4.07B | 4.93B |
| Net Income | 15.03B | 11.03B | 9.09B | 13.39B | 16.86B |
| Net Margin | 26.0% | 17.7% | 10.3% | 13.0% | 14.7% |
| EPS (Basic) | 8.16 | 6.23 | 5.24 | 8.04 | 10.34 |
| EPS (Diluted) | 8.03 | 6.15 | 5.18 | 7.95 | 10.20 |
| Weighted Avg Shares | 1.79B | 1.69B | 1.63B | 1.59B | 1.57B |
| Weighted Avg Shares (Diluted) | 1.81B | 1.71B | 1.65B | 1.61B | 1.59B |
Morgan Stanley
NYSE:MS
Intrinsic Alpha fair value
Locked
Current Price
$181.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.